Overview
Toshiya Inaba practices in Hiroshima, Japan. Inaba is rated as an Elite expert by MediFind in the treatment of Chromosome 7p Deletion. Their top areas of expertise are Chromosome 7p Deletion, Leukemia, Myelodysplastic Syndrome (MDS), and Acute Lymphoblastic Leukemia (ALL).
Their clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Chromosome 7p Deletion.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chromosome 7p Deletion
- Advanced
- LeukemiaInaba isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Inaba isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Glucocorticoid ResistanceInaba isExperienced. Learn about Glucocorticoid Resistance.
- Mantle Cell Lymphoma (MCL)Inaba isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- MosaicismInaba isExperienced. Learn about Mosaicism.
- Non-Hodgkin LymphomaInaba isExperienced. Learn about Non-Hodgkin Lymphoma.